Skip to main content

SBI Securities Co., Ltd.

SEC CIK
0001851815
Latest filing
Jul 22, 2026

SLXN holding history

Silexion Therapeutics Corp in every 13F filed by SBI Securities Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLXN overviewAll 13F holders of SLXNFull Q2 2026 holdings

Shares (Q2 2026)
2
Value
$5
% of portfolio
<0.1%
Quarters held
6
Since Q1 2025
Holdings of SLXN by SBI Securities Co., Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262$5<0.1%−18−90.0%ReducedHolders
Q1 202620$26<0.1%−1,040−98.1%ReducedHolders
Q4 20251,060$2.04K<0.1%00.0%UnchangedHolders
Q3 20251,060$3.60K<0.1%−15,354−93.5%ReducedHolders
Q2 202516,414$13.3K<0.1%+30.0%AddedHolders
Q1 202516,411$18.1K<0.1%+16,411NewHolders